(Q36147087)

12 August 2017

title

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy (English)

1 reference

12 August 2017

Cesar A Migliorati

1

1 reference

12 August 2017

Mark M Schubert

series ordinal

2

1 reference

12 August 2017

Douglas E Peterson

series ordinal

3

1 reference

12 August 2017

Luis Marcelo Seneda

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

104

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

83-93

1 reference

Overview of bisphosphonates

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Future directions in the treatment and prevention of bone metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Aetiology of bone disease and the role of bisphosphonates in multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Severe oral ulcerations induced by alendronate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Dose density by any other name

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Osteonecrosis of the jaws associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Bisphosphonates and bone necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Bisphosphonate-induced osteopetrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Do bisphosphonates make children's bones better or brittle?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Something old, something few, something subjective, something déjà vu.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Ischemic osteonecrosis under fixed partial denture pontics: radiographicand microscopic features in 38 patients with chronic pain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Osteonecrosis: a multifactorial etiology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Intraosseous circulation from physiology to disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21130

7 January 2021

Identifiers

DOI

10.1002/CNCR.21130

1 reference

12 August 2017

1 reference